3 drug(s) with this reaction
37,602 total reports
Device Issue has been reported as an adverse reaction across 3 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 37,602 adverse event reports mention device issue in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with device issue, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have device issue listed in their FDA adverse event reports, sorted by report count:
In addition to device issue, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
3 drug(s) manufactured by Abbvie Inc have device issue listed in their FDA adverse event reports: Humira, ADALIMUMAB, RISANKIZUMAB-RZAA.
There are a combined 37,602 reports of device issue across 3 Abbvie Inc drug(s) in the FDA adverse event database.